476 related articles for article (PubMed ID: 19482086)
21. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
Sato Y
Int J Clin Oncol; 2003 Aug; 8(4):200-6. PubMed ID: 12955574
[TBL] [Abstract][Full Text] [Related]
22. Antiangiogenic therapy in malignant glioma: promise and challenge.
Sathornsumetee S; Rich JN
Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
[TBL] [Abstract][Full Text] [Related]
23. Anti-angiogenic therapies in cancer: achievements and open questions.
Ruegg C; Mutter N
Bull Cancer; 2007 Sep; 94(9):753-62. PubMed ID: 17878094
[TBL] [Abstract][Full Text] [Related]
24. Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms.
Miletic H; Niclou SP; Johansson M; Bjerkvig R
Expert Opin Ther Targets; 2009 Apr; 13(4):455-68. PubMed ID: 19335067
[TBL] [Abstract][Full Text] [Related]
25. Editorial: Angiogenesis agents.
Marcinkiewicz C
Curr Pharm Des; 2007; 13(35):3543-4. PubMed ID: 18220790
[No Abstract] [Full Text] [Related]
26. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
[TBL] [Abstract][Full Text] [Related]
27. Catecholamines regulate tumor angiogenesis.
Chakroborty D; Sarkar C; Basu B; Dasgupta PS; Basu S
Cancer Res; 2009 May; 69(9):3727-30. PubMed ID: 19383906
[TBL] [Abstract][Full Text] [Related]
28. Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.
Lopes-Coelho F; Martins F; Pereira SA; Serpa J
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916438
[TBL] [Abstract][Full Text] [Related]
29. Angiogenesis inhibitors in the treatment of prostate cancer.
Adesunloye BA; Karzai FH; Dahut WL
Chem Immunol Allergy; 2014; 99():197-215. PubMed ID: 24217611
[TBL] [Abstract][Full Text] [Related]
30. Editorial foreword special issue: "Angiogenesis-convergent or divergent, that is the question: Research toward targeted strategies in oncology".
Cai J
Cancer Lett; 2016 Oct; 380(2):523-524. PubMed ID: 27032878
[No Abstract] [Full Text] [Related]
31. Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth.
Paschoalin T; Carmona AK; Rodrigues EG; Oliveira V; Monteiro HP; Juliano MA; Juliano L; Travassos LR
Mol Cancer; 2007 Jul; 6():44. PubMed ID: 17620116
[TBL] [Abstract][Full Text] [Related]
32. Recent developments in tumor angiogenesis.
Kilarski WW; Bikfalvi A
Curr Pharm Biotechnol; 2007 Feb; 8(1):3-9. PubMed ID: 17311548
[TBL] [Abstract][Full Text] [Related]
33. The quest for surrogate markers of angiogenesis: a paradigm for translational research in tumor angiogenesis and anti-angiogenesis trials.
Rüegg C; Meuwly JY; Driscoll R; Werffeli P; Zaman K; Stupp R
Curr Mol Med; 2003 Dec; 3(8):673-91. PubMed ID: 14682490
[TBL] [Abstract][Full Text] [Related]
34. Type IV collagen-derived angiogenesis inhibitors.
Mundel TM; Kalluri R
Microvasc Res; 2007; 74(2-3):85-9. PubMed ID: 17602710
[TBL] [Abstract][Full Text] [Related]
35. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
Hamsa TP; Kuttan G
Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484
[TBL] [Abstract][Full Text] [Related]
36. The host support niche as a control point for tumor dormancy: implications for tumor development and beyond.
Hahnfeldt P
Adv Exp Med Biol; 2013; 734():19-35. PubMed ID: 23143973
[TBL] [Abstract][Full Text] [Related]
37. Ischemic vascular disease and solid cancers: opposing ends of the angiogenic spectrum?
Balasubramanian SP; Reed MW
Med Hypotheses; 2006; 67(6):1317-9. PubMed ID: 16828237
[TBL] [Abstract][Full Text] [Related]
38. Role of the tumor microenvironment in mediating response to anti-angiogenic therapy.
Jung YD; Ahmad SA; Akagi Y; Takahashi Y; Liu W; Reinmuth N; Shaheen RM; Fan F; Ellis LM
Cancer Metastasis Rev; 2000; 19(1-2):147-57. PubMed ID: 11191054
[TBL] [Abstract][Full Text] [Related]
39. Targeting tumor vascularization: promising strategies for vascular normalization.
Zheng R; Li F; Li F; Gong A
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2489-2505. PubMed ID: 34148156
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.
Dell'Eva R; Pfeffer U; Indraccolo S; Albini A; Noonan D
Endothelium; 2002; 9(1):3-10. PubMed ID: 12901356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
